Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pfizer (NY: PFE )

29.75 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Sep 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 22,777
Open 29.75
Bid (Size) 29.94 (1)
Ask (Size) 29.95 (1)
Prev. Close 29.75
Today's Range 29.75 - 29.75
52wk Range 25.20 - 34.11
Shares Outstanding 5,606,688,356
Dividend Yield 5.51%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Current Report: Pfizer (PFE)
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion. Over the past year, Pfizer's share price fell about 12.7% from $34.07 to $29.75 as of Wednesday’s... 
Via Talk Markets
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga

Performance

YTD
+0.07%
+0.07%
1 Month
+3.30%
+3.30%
3 Month
+7.25%
+7.25%
6 Month
+7.40%
+7.40%
1 Year
-12.47%
-12.47%

More News

Read More
Jim Cramer Labels Moderna A 'Big Disappointment,' But Suggests Doubling Down On Another Pharma Powerhouse
Via Benzinga
3 Magnificent Dividend Stocks With Yields Above 5% to Buy Now and Hold Forever
Via The Motley Fool
Prediction: These Could Be the Best-Performing Biotech Stocks Through 2030
Via The Motley Fool
Pfizer Unusual Options Activity
Via Benzinga
Beyond The Numbers: 13 Analysts Discuss Pfizer Stock
Via Benzinga
Is Pfizer's 5.7% Dividend Yield Worth the Risk?
Via The Motley Fool
Pfizer Invites Public to View and Listen to Webcast of October 29 Conference Call with Analysts
From Pfizer Inc.
Via Business Wire
1 Telemedicine Stock I Wouldn't Touch With a 10-Foot Pole (Hint: It's Not Teladoc)
Via The Motley Fool
Buy 3 High Dividend-Paying Stocks With Attractive Short-Term Returns
Via Talk Markets
Intel, Microsoft, Meta Platforms, Pfizer, Tesla: Why These 5 Stocks Are On Investors' Radars Today
Via Benzinga
Topics Stocks
Exposures US Equities
Is Pfizer Stock Going to $36? 1 Wall Street Analyst Thinks So.
Via The Motley Fool
Topics Supply Chain
Exposures Supply Chain
DeSantis Administration Cautions Against Pfizer, Moderna mRNA Covid Vaccines for Vulnerable Individuals, Cites Concerns Related To Rare Heart Conditions
Via Benzinga
Exposures COVID-19
Kalm Therapeutics Hires Former GSK Director Dr. Tomoko Maeda-Chubachi as Chief Medical Officer
Via Newsfile
Pfizer Presents Positive Data from Phase 2 Study of Ponsegromab in Patients with Cancer Cachexia
From Pfizer Inc.
Via Business Wire
Pfizer’s BRAFTOVI® + MEKTOVI® Shows Long-Term Clinically Meaningful Response in Patients with BRAF V600E-Mutant Metastatic Non-Small Cell Lung Cancer
From Pfizer Inc.
Via Business Wire
Time To Invest And Or Trade In Bio-Tech Stocks?
Via Talk Markets
Topics ETFs
Moderna's Pain Continues Amid Flurry Of Downgrades Following 'Tough' R&D Day
Via Investor's Business Daily
Got $5,000? 3 Dirt Cheap Stocks to Buy Right Now
Via The Motley Fool
Should You Buy Novavax Stock After This Regulatory Win?
Via The Motley Fool
A Bull Market Is Here: 2 High-Potential Stocks Down More Than 50% to Buy Right Now
Via The Motley Fool
Alnylam Stock Soars 65%: Find Out What’s Behind the Gains
Via MarketBeat
Exposures Product Safety
UnitedHealth Follows Competitors, Replaces Humira with Lower-Cost Biosimilars
Via Benzinga
GSK Halts Herpes Simplex Virus Vaccine Development, Clears Path For Other Contenders Like Moderna, BioNTech
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.